This fact sheet outlines PATH's pneumococcal vaccine project from a technical perspective. It includes an overview of PATH's vaccine development portfolio and partners to support the development of vaccines against pneumonia and other pneumococcal diseases that can be effective and affordable for children in the developing world.

Publication date: April 2018

Region: Global

PATH is collaborating with the Novartis Foundation to introduce an innovative healthcare delivery model designed to improve hypertension management and control in Vietnam. The project aims to improve blood pressure control among adults by increasing access to and use of high-quality hypertension services that are sustainable and scalable.

Publication date: March 2018

Region: Asia, Global

In Vietnam, the USAID/PATH Healthy Markets project is collaborating with MTV Vietnam to empower young people to prevent and manage HIV. Healthy Markets and MTV Vietnam have now reached more than 1.5 million people with information about new services and products, like community-based HIV testing and pre-exposure prophylaxis, and is encouraging open conversations about HIV, safe sex, and being LGBT+ in Vietnam.

Publication date: March 2018

Region: Asia, Global

Blow-fill-seal (BFS) technologies use a polymer material to form the container. BFS is widely used for packaging of single-dose pharmaceuticals, but has yet to be introduced for vaccines. The BFS manufacturing process can accommodate the filling of multiple containers into a single strip with a flexible detachment point, allowing for the easy separation of each unit-dose container at the point of delivery.

Publication date: February 2018

Region: Global

Part of series: Technology Updates

Part of the Technology Updates series, this fact sheet describes PATH's work on designing the next generation of jet injectors.

Publication date: February 2018

Region: Global

Part of series: Technology Updates

This Vaccine and Pharmaceutical Technologies documents answers frequently asked questions regarding one type of freeze-preventive vaccine carrier. It includes why vaccine freezing is a problem, the benefits of freeze-preventive carriers, and the next steps for the technology.

Publication date: February 2018

Region: Global

Part of the Technology Updates series, this fact sheet describes PATH’s work on freeze-preventive vaccine carriers to address the problem of vaccines freezing during transport.

Publication date: February 2018

Region: Global

Part of series: Technology Updates

Part of the Technology Updates series, this fact sheet describes PATH's work on an intradermal adapter, which makes it easier to administer intradermal injections.

Publication date: February 2018

Region: Global

Part of series: Technology Updates

PATH and its partners are in the early stages of developing microarray patches (MAPs) containing cabotegravir for HIV pre-exposure prophylaxis (PrEP), as well as a MAP containing cabotegravir and a contraceptive—a multipurpose protection technology (MPT).

Publication date: February 2018

Region: Global

PATH’s global community of donors and partners stepped up to support health equity through the Reach Campaign, our first major fundraising initiative. This report shares the final campaign results, including what PATH donors have made possible through their support.

Publication date: February 2018

Region: Global

Part of series: Reports to contributors

Part of the Technology Updates series, this fact sheet describes PATH's work on technologies to make the reconstitution of critical vaccines simpler, safer, and more economical. Streamlined reconstitution processes also help reduce medical wastage.

Publication date: February 2018

Region: Global

Part of series: Technology Updates

Advocacy is an effective method to achieve global health goals by ensuring that necessary resources, policies, and political will are available to support important programs. These resources help new and experienced advocates assess policy advocacy options, plan goals and activities, and develop a comprehensive strategy for advocacy impact. For more information, please visit: http://sites.path.org/advocacyandpolicy/how-we-do-it/strengthen-advocacy-capacity/.

Publication date: February 2018

Region: Africa, Asia, Global

This publication captures the milestones and process used by PATH in its role as Market Manager for the introduction and scale of 7.1% chlorhexidine for umbilical cord care globally over the last ten years.

Publication date: January 2018

Region: Global

Subcutaneous DMPA is an innovative injectable contraceptive that can dramatically expand access and choice for women. A new initiative led by PATH and John Snow Inc., the Subcutaneous DMPA Access Collaborative is working with ministries of health and partners across sectors to strengthen scale-up and build toward a robust global market for the product. For more information, visit http://sites.path.org/rh/?p=292.

Publication date: January 2018

Region: Global

PATH and Johnson & Johnson Vietnam are collaborating on Breath for Life, a new project to reduce childhood tuberculosis (TB) illness and death in Vietnam. Breath for life will strengthen the detection, treatment, and management of TB in children in NgheAn, a province highly burdened by TB, in partnership with the Vietnam National Tuberculosis Programme.

Publication date: November 2017

Region: Asia

In low-transmission settings, submicroscopic quantities of Plasmodium falciparum are undetectable by current rapid diagnostic tests and ELISAs. Detection of this reservoir is essential, and we need a highly sensitive laboratory reference assay to confirm these infections. This study aimed to characterize the analytical and diagnostic performance of Alere’s high-sensitivity test.

Author: Das S, Jang I, Barney B, Peck R, Rek J, Arinaitwe E, Adrama H, Murphy M, Imwong M, Ling C, Proux S, Haohankhunnatham W, Seilie A, Hanron A, Daza G, Chang M, Nakamura T, Kalnoky M, LaBarre P, Murphy S, Nosten F, Greenhouse B, Domingo G

Publication date: November 2017

Region: Global

Part of series: ASTMH posters

Lymphatic filariasis is caused primarily by Wuchereria bancrofti (Wb) and can be co-endemic with certain filarial parasites in central Africa. Two new IgG4 rapid diagnostic tests (RDTs) are available from Standard Diagnostics, Inc. The aim of this research was to determine the specificity of the Wb123 RDTs in co-endemic zones.

Author: Golden A, Storey H, Gerth-Guyette E, Kalnoky M, Njouendou J, Ekanya R, Mbeng A, Ndzeshang B,

Publication date: November 2017

Region: Africa

Part of series: ASTMH posters

This trial evaluated two malaria control approaches: reactive focal test and treat, and reactive focal drug administration. This is critical for Zambia, where malaria transmission is low enough in some areas that it is feasible to reactively seek and treat all infections in the index case and neighboring households.

Publication date: November 2017

Region: Africa

Part of series: ASTMH posters

PATH’s Scale-Up project works to expand the use of human papillomavirus (HPV) testing for cervical cancer prevention. Based on PATH’s experience implementing the careHPV™ test in Central America, this manual, available in Spanish and English, provides guidance for organizing a quality assurance program to screening programs adopting the careHPV test.

Publication date: November 2017

Region: Latin America, Global

Kenya’s Hospital Medicine and Therapeutic Committees (HMTCs) evaluate clinical drug use and assure review of hospital outcomes. Unfortunately, few hospitals have functioning committees. MalariaCare worked to revive HMTCs to strengthen malaria case management. This report describes effects on malaria case management and health systems in Migori County Referral Hospital.

Author: Marube E, Chahale T, Onyando B, Onditi S, Clark T, Illah E, Dena R, Kolek C, Martin T

Publication date: November 2017

Region: Africa

Part of series: ASTMH posters